NCT02943590View on ClinicalTrials.gov

STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 13, 2017

Primary Completion Date

September 16, 2022

Study Completion Date

October 11, 2023

Conditions
Heart Failure
Interventions
DRUG

Placebo

A pill taken once a day

DRUG

Atorvastatin

A pill taken once a day

Trial Locations (4)

19104

University of Pennsylvania Medical System, Philadelphia

02114

Massachusetts general Hospital, Boston

02115

Dana Farber Cancer Institute, Boston

Unknown

McGill University Health Center, Toronto

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02943590 - STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines) | Biotech Hunter | Biotech Hunter